Published in Lancet on March 12, 2013
Progression of coronary artery calcification seems to be inevitable, but predictable - results of the Heinz Nixdorf Recall (HNR) study. Eur Heart J (2014) 2.23
Immunity, atherosclerosis and cardiovascular disease. BMC Med (2013) 1.49
Raising the pressure on hypertension. Lancet (2013) 1.41
Atherosclerosis in ancient populations. Lancet (2013) 1.09
Proinflammation: the key to arterial aging. Trends Endocrinol Metab (2013) 1.07
So! What's aging? Is cardiovascular aging a disease? J Mol Cell Cardiol (2015) 0.88
Air pollution and public health: emerging hazards and improved understanding of risk. Environ Geochem Health (2015) 0.88
Checklist and Scoring System for the Assessment of Soft Tissue Preservation in CT Examinations of Human Mummies. PLoS One (2015) 0.87
Vascular calcification: an age-old problem of old age. Circulation (2013) 0.84
MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases. Biochim Biophys Acta (2016) 0.84
Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver Disease. PLoS One (2014) 0.81
The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis. Ann N Y Acad Sci (2014) 0.81
Radiological findings in an ancient Iranian salt mummy (Chehrābād ca. 410-350 BC). Skeletal Radiol (2015) 0.79
Evolution of Myocardial Infarction and its Biomarkers: A Historical Perspective. Heart Views (2017) 0.79
The telomeric sync model of speciation: species-wide telomere erosion triggers cycles of transposon-mediated genomic rearrangements, which underlie the saltatory appearance of nonadaptive characters. Naturwissenschaften (2014) 0.79
If there is an evolutionary selection pressure for the high frequency of MBL2 polymorphisms, what is it? Clin Exp Immunol (2014) 0.79
Loss of apoptosis regulator through modulating IAP expression (ARIA) protects blood vessels from atherosclerosis. J Biol Chem (2014) 0.79
Assessment of the body composition and parameters of the cardiovascular risk in juvenile idiopathic arthritis. Biomed Res Int (2015) 0.78
Coronary artery disease: Complex association between height and CHD-size matters. Nat Rev Cardiol (2015) 0.77
Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular Inflammation. Front Immunol (2016) 0.76
Cardiovascular disease and type 2 diabetes in evolutionary perspective: a critical role for helminths? Evol Med Public Health (2016) 0.76
Mitochondrial health, the epigenome and healthspan. Clin Sci (Lond) (2016) 0.76
Scanning ancient history for evidence of modern diseases. Lancet (2013) 0.75
Early Detection System of Vascular Disease and Its Application Prospect. Biomed Res Int (2016) 0.75
[Contribution of paleopathology to the knowledge of the natural history of chronic pathologies: the example of atherosclerosis]. Bull Cancer (2013) 0.75
Atherosclerosis in ancient populations - Authors' reply. Lancet (2013) 0.75
Vascular disease: Atherosclerosis unravelled--clues from ancient civilizations. Nat Rev Cardiol (2013) 0.75
Anatomical confirmation of computed tomography-based diagnosis of the atherosclerosis discovered in 17th century Korean mummy. PLoS One (2015) 0.75
Application of quality by design (QbD) approach to ultrasonic atomization spray coating of drug-eluting stents. AAPS PharmSciTech (2015) 0.75
Invasive versus Non Invasive Methods Applied to Mummy Research: Will This Controversy Ever Be Solved? Biomed Res Int (2015) 0.75
Darwinian evolution and cardiovascular remodeling. Heart Fail Rev (2016) 0.75
Coronary Heart Disease: From Mummies to 21(st) Century. Heart Views (2017) 0.75
Paleogenetic study on the 17th century Korean mummy with atherosclerotic cardiovascular disease. PLoS One (2017) 0.75
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol (2009) 5.70
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med (2008) 5.62
Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med (2003) 5.43
Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci (2004) 5.10
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A (2003) 4.80
Evolutionary medicine: from dwarf model systems to healthy centenarians? Science (2003) 4.31
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 4.29
A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science (2008) 3.95
Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr (2010) 3.80
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat Biotechnol (2009) 3.78
Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol (2010) 3.45
In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol (2013) 3.43
Functional annotation and network reconstruction through cross-platform integration of microarray data. Nat Biotechnol (2005) 3.30
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol (2010) 3.21
Infection, inflammation, height, and longevity. Proc Natl Acad Sci U S A (2005) 3.17
Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol (2007) 2.97
Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol (2009) 2.93
Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry (2003) 2.85
Cytokines and cognition--the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc (2002) 2.79
We are all for elevating VR…. JACC Cardiovasc Imaging (2011) 2.62
Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol (2002) 2.52
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation (2007) 2.50
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol (2011) 2.48
OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging (2013) 2.31
Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One (2010) 2.26
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res (2003) 2.08
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol (2010) 2.07
Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A (2002) 1.98
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol (2008) 1.97
Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol Aging (2004) 1.97
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. JACC Cardiovasc Imaging (2009) 1.92
Left ventricular structure and function: basic science for cardiac imaging. J Am Coll Cardiol (2006) 1.92
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 1.87
Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging (2012) 1.85
Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol (2013) 1.84
Atherosclerosis in ancient Egyptian mummies: the Horus study. JACC Cardiovasc Imaging (2011) 1.83
Characterization and quantification of vortex flow in the human left ventricle by contrast echocardiography using vector particle image velocimetry. JACC Cardiovasc Imaging (2008) 1.79
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.79
Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol (2007) 1.78
Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging (2012) 1.77
Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med (2005) 1.75
Assessing the need for nuclear cardiology and other advanced cardiac imaging modalities in the developing world. J Nucl Cardiol (2009) 1.73
Cardiologist concordance with the American College of Cardiology appropriate use criteria for cardiac testing in patients with coronary artery disease. Am J Cardiol (2012) 1.70
Why all the focus on cardiac imaging? JACC Cardiovasc Imaging (2010) 1.68
Computed tomographic assessment of atherosclerosis in ancient Egyptian mummies. JAMA (2009) 1.67
Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC Cardiovasc Imaging (2008) 1.67
Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J Neurosci (2002) 1.66
Left ventricular form and function revisited: applied translational science to cardiovascular ultrasound imaging. J Am Soc Echocardiogr (2007) 1.65
American Society of Echocardiography: Remote Echocardiography with Web-Based Assessments for Referrals at a Distance (ASE-REWARD) Study. J Am Soc Echocardiogr (2013) 1.62
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. JACC Cardiovasc Imaging (2009) 1.61
Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis. J Nucl Cardiol (2009) 1.60
Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events. JACC Cardiovasc Imaging (2009) 1.58
Differential patterns of age-related mortality increase in middle age and old age. J Gerontol A Biol Sci Med Sci (2003) 1.57
What accounts for the wide variation in life span of genetically identical organisms reared in a constant environment? Mech Ageing Dev (2005) 1.57
Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation (2003) 1.55
Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. Eur Heart J (2011) 1.53
Integrating coronary anastomotic connectors and robotics toward a totally endoscopic beating heart approach: review of 120 cases. Ann Thorac Surg (2011) 1.52
Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification. JACC Cardiovasc Imaging (2013) 1.52
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol (2012) 1.51
Multimodality Intravascular Imaging to Evaluate Sex Differences in Plaque Morphology in Stable CAD. JACC Cardiovasc Imaging (2016) 1.51
Should old acquaintance be forgot: Auld Lang Syne Q waves! JACC Cardiovasc Imaging (2013) 1.49
Ageing: the old worm turns more slowly. Nature (2002) 1.49
Computed tomographic angiography-verified plaque characteristics and slow-flow phenomenon during percutaneous coronary intervention. JACC Cardiovasc Interv (2012) 1.49
The rise and fall of excess male infant mortality. Proc Natl Acad Sci U S A (2008) 1.47
Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation (2003) 1.46
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trials. J Nucl Cardiol (2014) 1.45
Molecular imaging of human ACE-1 expression in transgenic rats. JACC Cardiovasc Imaging (2012) 1.45
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol (2013) 1.44
Combined NIRS and IVUS imaging detects vulnerable plaque using a single catheter system: a head-to-head comparison with OCT. EuroIntervention (2014) 1.44
Risk factors for heart failure. Med Clin North Am (2004) 1.43
Digital Mammography and Screening for Coronary Artery Disease. JACC Cardiovasc Imaging (2016) 1.41
Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol (2011) 1.39
Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med (2004) 1.34